These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29548722)

  • 21. Apolipoprotein E as vascular risk factor in neurodegenerative dementia.
    Folin M; Baiguera S; Conconi MT; Di Liddo R; De Carlo E; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2004 Oct; 14(4):609-13. PubMed ID: 15375590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of lipid metabolism gene SAR1 homolog B and the risk of Alzheimer's disease and vascular dementia.
    Chen JH; Hsieh CJ; Huang YL; Chen YC; Chen TF; Sun Y; Wen LL; Yip PK; Chu YM
    J Formos Med Assoc; 2016 Jan; 115(1):38-44. PubMed ID: 25703997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
    Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
    Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE genotype in cerebrovascular disease and vascular dementia.
    Frank A; Díez-Tejedor E; Bullido MJ; Valdivieso F; Barreiro P
    J Neurol Sci; 2002 Nov; 203-204():173-6. PubMed ID: 12417379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years.
    Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between apolipoprotein E, dementia, and vascular illness.
    Marin DB; Breuer B; Marin ML; Silverman J; Schmeidler J; Greenberg D; Flynn S; Mare M; Lantz M; Libow L; Neufeld R; Altstiel L; Davis KL; Mohs RC
    Atherosclerosis; 1998 Sep; 140(1):173-80. PubMed ID: 9733229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.
    Traykov L; Rigaud AS; Baudic S; Smagghe A; Boller F; Forette F
    J Neurol Sci; 2002 Nov; 203-204():177-81. PubMed ID: 12417380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.
    Molero AE; Pino-Ramírez G; Maestre GE
    Neurosci Lett; 2001 Jul; 307(1):5-8. PubMed ID: 11516561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.
    Nakayama S; Kuzuhara S
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
    Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
    Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease.
    Flex A; Gaetani E; Proia AS; Pecorini G; Straface G; Biscetti F; Fioroni G; Sabusco A; Flore R; Tondi P; Pola P; Pola R
    J Gerontol A Biol Sci Med Sci; 2006 Oct; 61(10):1065-9. PubMed ID: 17077200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathology.
    Chemparathy A; Le Guen Y; Chen S; Lee EG; Leong L; Gorzynski JE; Jensen TD; Ferrasse A; Xu G; Xiang H; Belloy ME; Kasireddy N; Peña-Tauber A; Williams K; Stewart I; Talozzi L; Wingo TS; Lah JJ; Jayadev S; Hales CM; Peskind E; Child DD; Roeber S; Keene CD; Cong L; Ashley EA; Yu CE; Greicius MD
    Neuron; 2024 Apr; 112(7):1110-1116.e5. PubMed ID: 38301647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E gene in physiological and pathological aging.
    Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
    Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
    Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
    Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.
    Singleton AB; Wharton A; O'Brien KK; Walker MP; McKeith IG; Ballard CG; O'Brien J; Perry RH; Ince PG; Edwardson JA; Morris CM
    Dement Geriatr Cogn Disord; 2002; 14(4):167-75. PubMed ID: 12411758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.